Effect of PCSK9 Inhibitors on Systemic Immune Inflammation Index and Cardiovascular Risk in Patients with Ultra-High-Risk ASCVD Combined with CKD

Advances in Clinical Medicine, Год журнала: 2025, Номер 15(03), С. 859 - 869

Опубликована: Янв. 1, 2025

Язык: Английский